Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Santiago Sambracos Parrado"'
Autor:
Julieth Vivian Sarmiento Palma, Santiago Sambracos Parrado, Maria Camila Echeverria, Paula Ruiz Talero
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 17 (2024)
We report the case of a 27-year-old man with transthyretin amyloidosis secondary to the p.Val142Ile mutation with an atypical clinical presentation of predominantly lower limb polyneuropathy without cardiac involvement. p.Val142Ile is mainly associat
Externí odkaz:
https://doaj.org/article/b6bdd5c63eb84165aec5d5a08af63b28
Autor:
Juliana Rodríguez-Carrillo, Juan Mauricio Pardo-Oviedo, Santiago Sambracos-Parrado, María Fernanda Leal, Nora Contreras Contreras Bravo, David Corredor-Orlandelli, Oscar Ortega-Recalde, Valentina Vega-Ramírez, Katherine Parra Abaunza, Santiago David Mendoza-Ayús, Josué Tovar-Tirado, Laura Peña, Dora Janeth Fonseca Mendoza, Juanita León-Torres, Santiago Mantilla-García
Publikováno v:
Vascular Health and Risk Management
David Corredor-Orlandelli,1,* Santiago Sambracos-Parrado,1,* Santiago Mantilla-García,1 Josué Tovar-Tirado,1 Valentina Vega-Ramírez,1 Santiago David Mendoza-Ayús,1 Laura Catalina Peña,1 María Fernanda Leal,1 Juliana Rodríguez-Carrillo,1 Juanit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed9edf1f0539d5406389ad773d3e50b
https://doi.org/10.2147/vhrm.s330766
https://doi.org/10.2147/vhrm.s330766
Autor:
Mariana, Angulo-Aguado, Karen, Panche, Caroll Andrea, Tamayo-Agudelo, Daniel-Armando, Ruiz-Torres, Santiago, Sambracos-Parrado, Maria Jose, Niño-Orrego, Nathaly, Páez, Laura B, Piñeros-Hernandez, Luisa-Fernanda, Castillo-León, Juan Mauricio, Pardo-Oviedo, Katherine Parra, Abaunza, Paul, Laissue, Nora, Contreras, Carlos Alberto, Calderón-Ospina, Dora Janeth, Fonseca-Mendoza
Publikováno v:
Journal of Personalized Medicine
Clopidogrel, an oral platelet P2Y12 receptor blocker, is used in the treatment of acute coronary syndrome. Interindividual variability in treatment response and the occurrence of adverse effects has been attributed to genetic variants in CYP2C19. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4a1ee31e5a1ed075b0b1a37549111fb
https://pubmed.ncbi.nlm.nih.gov/34065778
https://pubmed.ncbi.nlm.nih.gov/34065778
Autor:
Nora Contreras, Nathaly Páez, Dora Janeth Fonseca-Mendoza, Caroll Tamayo-Agudelo, Santiago Sambracos-Parrado, Juan Mauricio Pardo-Oviedo, Karen Panche, Maria Jose Niño-Orrego, Katherine Parra Abaunza, Daniel Armando Ruiz-Torres, Laura B. Piñeros-Hernández, Carlos Alberto Calderón-Ospina, Luisa Fernanda Castillo-León, Paul Laissue, Mariana Angulo-Aguado
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 400, p 400 (2021)
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 400, p 400 (2021)
Clopidogrel, an oral platelet P2Y12 receptor blocker, is used in the treatment of acute coronary syndrome. Interindividual variability in treatment response and the occurrence of adverse effects has been attributed to genetic variants in CYP2C19. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e7cb13ebce266d996f1e4c1e7b384b
https://doi.org/10.3390/jpm11050400
https://doi.org/10.3390/jpm11050400